Search
Search Results
##search.searchResults.foundPlural##
-
CYTOMEGALOVIRUS REACTIVATION IN ADULT RECIPIENTS OF AUTOLOGOUS STEM CELL TRANSPLANTATION: A SINGLE CENTER EXPERIENCE
1503PDF: 856HTML: 964figures: 153table 1: 163table2: 161table3: 162 -
DIAGNOSTIC VALUE OF BRONCHOALVEOLAR LAVAGE IN LEUKEMIC AND BONE MARROW TRANSPLANT PATIENTS: THE IMPACT OF ANTIMICROBIAL THERAPY
1905PDF: 789HTML: 2187Table 1: 158Table 2: 173Table 3: 169Table 4: 174Table 5: 171Tble 6: 164Cover Letter: 185Greene Tab.7: 169 -
Prof, Bruno Bizzi Obituary Bizzi Obituary
684HTML: 100PDF: 1067 -
PLASMABLASTIC LYMPHOMA. A STATE-OF-THE-ART REVIEW (1) Part 1- Epidemiology, pathogenesis, clinicopathologic characteristics, differential diagnosis, prognostic factors and special populations
3425PDF: 2333HTML: 1411 -
NPM1 MUTATED, BCR-ABL1 POSITIVE MYELOID NEOPLASMS: REVIEW OF LITERATURE NPM1 mutated, BCR-ABL1 positive myeloid neoplasms
1543PDF: 1134HTML: 182 -
HEMOGLOBIN ANALYSIS IN THE FIRST YEAR OF LIFE
3386PDF: 988HTML: 3008 -
THE ROLE OF INFECTION IN THE PATHOGENESIS OF VASO-OCCLUSIVE CRISIS IN PATIENTS WITH SICKLE CELL DISEASE.
5049PDF: 1288HTML: 2725Cover letter: 174 -
CONTINUOUS CULTURES OF PLASMODIUM FALCIPARUM ESTABLISHED IN TANZANIA FROM PATIENTS WITH ACUTE MALARIA In vitro Malaria cultures
1561PDF: 506HTML: 196 -
EBV-RELATED LYMPHOPROLIFERATIVE DISEASES: A REVIEW IN LIGHT OF NEW CLASSIFICATIONS EBV-RELATED LYMPHOPROLIFERATIVE DISEASES
3995PDF: 1534HTML: 834 -
Routine inflammatory markers are elevated in myelodysplastic syndromes at presentation Inflammatory marker elevation in MDS
809PDF: 617HTML: 187 -
COMPARISON OF INFECTIOUS COMPLICATIONS IN PATIENTS RECEIVING HIGH-DOSE CYCLOPHOSPHAMIDE AS GVHD AFTER TRANSPLANTATION FROM A 9/10 HLA-MATCHED UNRELATED DONOR WITH STANDARD GVHD PROPHYLAXIS AFTER TRANSPLANT FROM A FULL MATCHING DONOR Infection With PTCy Versus Standard GvHD Prophylaxis
1321PDF: 1270HTML: 79 -
SHORT HISTORY OF MALARIA AND ITS ERADICATION IN ITALY
4557PDF: 1819HTML: 10999Fig 1: 205Fig 2: 161Fig 3: 284Fig 4: 160Fig 5: 152Fig 6: 157Fig 7: 168Fig 8: 156 -
REAL-WORLD OUTCOME IN THE PRE-CAR-T ERA OF MYELOMA PATIENTS QUALIFYING FOR CAR-T CELL THERAPY Real-world Assessment of Myeloma Patients as Candidates for CAR-T Therapy
1479PDF: 560HTML: 170 -
TREATMENT OUTCOMES AND CLINICAL RELEVANCE IN PATIENTS WITH DOUBLE EXPRESSOR DLBCL Sirapat Rungwittayatiwat1, Paisarn Boonsakan2, Pichika Chantrathammachart1, Teeraya Puavilai1, Sulada Pukiat1, Sithakom Phusanti1,3, Kochawan Boonyawat1, Pathawut Wacharapornin1, Pantep Angchaisuksiri1, Artit Ungkanont1,3, Suporn Chuncharunee1 Pimjai Niparuck1
1042PDF: 463HTML: 167 -
APPLICATION OF NEW DRUGS IN CHRONIC LYMPHOCYTIC LEUKEMIA
1618PDF: 623HTML: 2413 -
Brain abscesses caused by Nocardia paucivorans in a multiple myeloma patient treated with lenalidomide and dexamethasone: a case report and review of literature.
1641PDF: 1065HTML: 6500original file with images: 250 -
EPIDEMIOLOGY OF IMPORTED MALARIA IN THE MEDITERRANEAN REGION
3042PDF: 1014HTML: 16390 -
IMPLEMENTATION OF MICROELIMINATION STRATEGY IN ERADICATION OF CHRONIC HEPATITIS C INFECTION IN PATIENTS WITH HEMOPHILIA IN THE NORTHERN REGION OF SERBIA Microelimination Strategy of Chronic Hepatitis C Infection in patients with Hemophilia
801PDF: 310HTML: 138 -
Impact of SARS CoV-2 in hemoglobinopathies: a protective mechanism being from Beta chain Hemoglobin defects? SARS-CoV-2 and Hemoglobinopathies
1505PDF: 886HTML: 376 -
GENETIC HETEROGENEITY OF BETA GLOBIN MUTATIONS AMONG ASIAN-INDIANS AND IMPORTANCE IN GENETIC COUNSELLING AND DIAGNOSIS
1700PDF: 1252HTML: 11437Figure1: 150Figure 2: 154 -
Early Diagnosis of Gaucher Disease and ASMD in Sardinia: the “ICHNOS” Project
542PDF: 393Suppl. Files: 116Html: 115 -
THALASSEMIA AND VENOUS THROMBOEMBOLISM
2865PDF: 980HTML: 4561 -
-
CMV IN HEMATOPOIETIC STEM CELL TRANSPLANTATION
4706PDF: 1707HTML: 2686Untitled: 190 -
LOW INCIDENCE RATE OF OPPORTUNISTIC AND VIRAL INFECTIONS DURING IMATINIB TREATMENT IN CHRONIC MYELOID LEUKEMIA PATIENTS IN EARLY AND LATE CHRONIC PHASE
1536PDF: 768HTML: 839jdoe, table 2 infections CML .doc: 174jdoe, table 1 infections CML .doc: 161







